HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrazolesIbipinabant
Chemical structure of CAS 464213-10-3

Ibipinabant

CAS No.464213-10-3
MDL No.MFCD07370146
MFC23H20Cl2N4O2S
MW487.40
InChI KeyAXJQVVLKUYCICH-OAQYLSRUSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.464213-10-3
Product NameIbipinabant

Biological Targets

CNR1

Associated Conditions

type 2 diabetes mellitus·obesity
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Cannabinoid receptor antagonist-induced striated muscle toxicity and ethylmalonic-adipic aciduria in beagle dogs.

Toxicological sciences : an official journal of the Society of Toxicology • Vol. 129, Issue 2 • 2012
PMID: 22821849DOI: 10.1093/toxsci/kfs217

Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.

Journal of medicinal chemistry • Vol. 50, Issue 24 • 2007
PMID: 17979261DOI: 10.1021/jm061490u

Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.

Journal of medicinal chemistry • Vol. 47, Issue 3 • 2004
PMID: 14736243DOI: 10.1021/jm031019q

Documentation